dc.contributor.author |
Uwaydah, Marwan |
|
dc.contributor.author |
Vartivarian, Shahe |
|
dc.contributor.author |
Harakeh, Hani |
|
dc.contributor.author |
Awdeh, Adnan |
|
dc.contributor.author |
Najjar, Faysal |
|
dc.date.accessioned |
2019-05-22T06:39:13Z |
|
dc.date.available |
2019-05-22T06:39:13Z |
|
dc.date.copyright |
1985 |
en_US |
dc.date.issued |
2019-05-22 |
|
dc.identifier.issn |
1179-1950 |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10725/10647 |
|
dc.description.abstract |
Temocillin concentrations were determined in the gallbladder bile and/or common bile duct bile obtained intraoperatively from 20 patients, and in the T-tube bile of 5 postoperative patients. Blood samples were also obtained for determining the concomitant serum antibiotic concentrations.
In 6 patients with cholelithiasis, but without common bile duct obstruction or acute infection, the mean temocillin concentrations were 890 mg/L in gallbladder bile and 1030 mg/L in common bile duct bile. In the group of 6 patients with common bile duct obstruction, the antibiotic concentrations ranged between 5.6 and 88 mg/L (mean 38.8 mg/L) in gallbladder bile and between ‘undetectable’ and 700 mg/L in common bile duct bile. In patients with biliary sepsis, a further reduction in temocillin bile concentrations was observed, and postoperatively, the T-tube bile temocillin concentrations were in the range of 21 to 460 mg/L (mean 130 mg/L). The clinical efficacy of temocillin in the 7 patients with acute cholecystitis was judged to be satisfactory. Our results suggest that temocillin may be considered as a potentially useful antibiotic in the treatment of patients with biliary tract sepsis caused by susceptible organisms. |
en_US |
dc.language.iso |
en |
en_US |
dc.title |
Potential role of temocillin in the treatment of biliary sepsis |
en_US |
dc.type |
Article |
en_US |
dc.description.version |
Published |
en_US |
dc.author.school |
SOM |
en_US |
dc.author.idnumber |
201000164 |
en_US |
dc.author.department |
N/A |
en_US |
dc.description.embargo |
N/A |
en_US |
dc.relation.journal |
Drugs |
en_US |
dc.journal.volume |
29 Supplement 5 |
en_US |
dc.article.pages |
186-190 |
en_US |
dc.keywords |
Commonb bile duct |
en_US |
dc.keywords |
Acute cholecystitis |
en_US |
dc.keywords |
Temocillin |
en_US |
dc.keywords |
Biliary tract disease |
en_US |
dc.keywords |
Gallbladder bile |
en_US |
dc.identifier.ctation |
Uwaydah, M., Vartivarian, S., Harakeh, H., Awdeh, A., & Najjar, F. (1985). Potential Role of Temocillin in the Treatment of Biliary Sepsis. Drugs, 29(5), 186-190. |
en_US |
dc.author.email |
adnan.awdeh@lau.edu.lb |
en_US |
dc.identifier.tou |
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php |
en_US |
dc.identifier.url |
https://link.springer.com/article/10.2165/00003495-198500295-00040 |
en_US |
dc.author.affiliation |
Lebanese American University |
en_US |